The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting.
NCT00265161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2007-06-01
Summary
The study will be held in the winter of 2005-2007. The aim is to assess the effectiveness of the influenza vaccine in health care workers (HCW).
Conditions
- Influenza Vaccines
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Principal Investigators
-
Dan Miron, MD · HaEmek Medicak Center, Afula, Israel
Eligibility
- Min Age
- 18 Days
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-12-31
- Completion
- 2007-03-31
Countries
- Israel
Study Locations
More Related Trials
-
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups
NCT00711295 ·Status: COMPLETED ·Phase: PHASE3
-
Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of Medical University of Warsaw
NCT04569019 ·Status: UNKNOWN
-
Evaluation of an Influenza Vaccination Implementation Strategy for Hospital Health Care Workers
NCT01481467 ·Status: UNKNOWN ·Phase: NA
-
Health Management Training to Enhance Influenza Vaccine Immunogenicity
NCT01256515 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
NCT00462215 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a School-based Influenza Vaccination Program
NCT00961337 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
NCT00349141 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Influenza Vaccination of Healthcare Workers (HCW) on the Risk of Influenza in Patients Hospitalized in Short Stays Units
NCT02198638 ·Status: COMPLETED ·Phase: NA
-
Prospective Monitoring of BNT162b2 Second Vaccination Booster Effects in Health Care Workers (HCW)
NCT05516459 ·Status: UNKNOWN
-
Influenza Vaccine Uptake Among Healthcare Workers
NCT05521763 ·Status: UNKNOWN ·Phase: NA
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults
NCT01776541 ·Status: COMPLETED ·Phase: PHASE2
-
Hutterite Influenza Prevention Study
NCT00877396 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals
NCT03816878 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation
NCT00946179 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults
NCT00895544 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)
NCT00289510 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign Planners
NCT01207518 ·Status: UNKNOWN ·Phase: NA
-
Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents
NCT01052402 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Effectiveness of a Flu Vaccination Campaign for Healthcare Workers of a Teaching Hospital: a Pre-post Study
NCT05783713 ·Status: COMPLETED
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
Inactivated Influenza Via Jet Injection
NCT02290691 ·Status: COMPLETED ·Phase: PHASE4
-
Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers
NCT04223544 ·Status: UNKNOWN
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)
NCT01551810 ·Status: COMPLETED ·Phase: PHASE3
-
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults
NCT01001026 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
NCT01258062 ·Status: COMPLETED ·Phase: PHASE1